Author headshot

Ashley Dombkowski, PhD

Ashley Dombkowski, PhD, is cofounder and CEO of Alladapt Immunotherapeutics.

Most recent by Ashley Dombkowski, PhD

SPONSORED CONTENT
November 30, 2023
7 min read
Save

Q&A: Single oral immunotherapy desensitizes children to multiple food allergens

ANAHEIM, Calif. — Children with allergies to multiple foods achieved desensitization with a multi-food oral immunotherapy, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

SPONSORED CONTENT
January 26, 2022
6 min read
Save

Q&A: Study to assess single oral immunotherapy’s ability to treat multiple food allergens

Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.